Cargando…
Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
Objective: To compare the effectiveness of second line injectables containing shorter (duration 9–12 months) and longer treatment regimens (LTR, duration ≥ 20 months) among multidrug-resistant tuberculosis (MDR-TB) patients with no documented resistance and history of treatment with any second-line...
Autores principales: | Wahid, Abdul, Ghafoor, Abdul, Khan, Abdul Wali, Al-Worafi, Yaser Mohammed, Latif, Abdullah, Shahwani, Nisar Ahmed, Atif, Muhammad, Saleem, Fahad, Ahmad, Nafees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503836/ https://www.ncbi.nlm.nih.gov/pubmed/36160454 http://dx.doi.org/10.3389/fphar.2022.973713 |
Ejemplares similares
-
Prognostic accuracy of time to sputum culture conversion in predicting cure in extensively drug-resistant tuberculosis patients: a multicentre retrospective observational study
por: Abubakar, Muhammad, et al.
Publicado: (2022) -
High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis
por: Naz, Farah, et al.
Publicado: (2021) -
Doctors' adherence to guidelines recommendations and glycaemic control in diabetic patients in Quetta, Pakistan: Findings from an observational study
por: Saher, Tabassum, et al.
Publicado: (2022) -
Treatment Outcomes of Extensively Drug-Resistant Tuberculosis in Pakistan: A Countrywide Retrospective Record Review
por: Abubakar, Muhammad, et al.
Publicado: (2021) -
Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis
por: Trubnikov, Aleksandr, et al.
Publicado: (2021)